Following the Taiwanese people's refusal to buckle to Chinese coercion in the January 13 elections, voting back into power the incumbent Democratic People's Party (DPP) with its new leader Lai Ching-te, opinion varies as to what Beijing's next course of action will be.
Former Taiwan President Tsai Ing-wen expressed gratitude to Tibetan spiritual leader Dalai Lama after he congratulated her colleague Lai Ching-te for winning third straight term for the Democratic Progressive Party (DPP) in Taiwanese presidential elections.
Democratic Progressive Party (DPP) candidate Lai Ching-te has won the much-anticipated Taiwanese presidential polls and is set to be the next President amid concerns of escalating tensions with China, Taiwan News reported.
The Chinese government has hinted at making further cuts to its free trade agreement if the Taiwanese government adheres to the path of Taiwan's independence.
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Taipei [Taiwan], January 2 (ANI): China warned Taipei of "decisive measures" following Taiwanese President Tsai Ing-wen's advice to Beijing to curb its military adventurism, reported local media.
Beijing [China], November 17 (ANI): China-Taiwan relationship has been strained for years but in a stern warning to Taipei, Beijing opposed "Taiwan independence" attempts through "law amendment."
Beijing [China], November 14 (ANI): Chinese Ambassador to the US Qin Gang condemned the Taiwanese political party Democratic Progressive Party (DPP) for seeking "Taiwan independence" during the 2021 annual meeting of Alliance for China's Peaceful Reunification (ACPR) in San Francisco, Chines
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.